CR

Chitralekha Rattan

Active Director Director DIN 06802165
DIN 06802165 First appointment Feb 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value •••• Premium profile

About Chitralekha Rattan

Data last updated:

Chitralekha Rattan is a Director at Blismed Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Blismed Pharmaceuticals Private Limited reported revenue of ₹50.8 Lakh (FY 2025).

DIN 06802165
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2014
Oldest Company Age 12 yrs
Largest company Blismed Pharmaceuticals Private Limited · ₹50.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Feb 20142014₹50.8 Lakh (FY 2025)Active

Board colleagues of Chitralekha Rattan

NameDINCompanyDesignation
Ranveer Rattan06802169Blismed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Blismed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chitralekha Rattan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chitralekha Rattan

Chitralekha Rattan currently holds 1 directorship: Blismed Pharmaceuticals Private Limited (Director, since 11 Feb 2014, revenue ₹50.8 Lakh (FY 2025)).

Chitralekha Rattan was first appointed on 11 Feb 2014 as Director at Blismed Pharmaceuticals Private Limited.

The current boards of Chitralekha Rattan's companies include Ranveer Rattan (Blismed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available